{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:52:24Z","timestamp":1785228744562,"version":"3.55.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T00:00:00Z","timestamp":1498176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0179798","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T17:42:04Z","timestamp":1498239724000},"page":"e0179798","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia"],"prefix":"10.1371","volume":"12","author":[{"given":"Peter M.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Caudell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Kucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M.","family":"Pladna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-6948","authenticated-orcid":true,"given":"Timothy S.","family":"Pardee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,23]]},"reference":[{"issue":"15","key":"ref1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia","volume":"350","author":"CH Pui","year":"2004","journal-title":"The New England journal of medicine"},{"key":"ref2","first-page":"e352","article-title":"Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: a broader range of options, improved outcomes, and more therapeutic dilemmas","volume":"2015","author":"AK Fielding","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/asheducation-2009.1.371","article-title":"Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"2009","author":"OG Ottmann","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"25","key":"ref4","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1182\/blood-2011-05-351403","article-title":"Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"118","author":"R Foa","year":"2011","journal-title":"Blood"},{"issue":"24","key":"ref5","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1182\/blood-2013-08-460311","article-title":"Genome sequencing of lymphoid malignancies","volume":"122","author":"CG Mullighan","year":"2013","journal-title":"Blood"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2013-09-529008","article-title":"UKALLXII\/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia","volume":"123","author":"AK Fielding","year":"2014","journal-title":"Blood"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ajh.21615","article-title":"Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study","volume":"85","author":"MB Lilly","year":"2010","journal-title":"American journal of hematology"},{"key":"ref8","article-title":"Tumor board review: guideline and case reviews in oncology","author":"RF Todd","year":"2015"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.leukres.2008.04.011","article-title":"Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and\/or at first relapse: results from the GET-LALA group","volume":"32","author":"O Reman","year":"2008","journal-title":"Leukemia research"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/cncr.25008","article-title":"Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies","volume":"116","author":"E Jabbour","year":"2010","journal-title":"Cancer"},{"key":"ref11","first-page":"13","article-title":"Treating the "older" adult with acute lymphoblastic leukemia","volume":"2010","author":"DI Marks","year":"2010","journal-title":"Hematology \/ the Education Program of the American Society of Hematology American Society of Hematology Education Program"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2141.2003.04386.x","article-title":"Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine","volume":"122","author":"CM Galmarini","year":"2003","journal-title":"British journal of haematology"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1365-2141.2002.03538.x","article-title":"In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia","volume":"117","author":"CM Galmarini","year":"2002","journal-title":"British journal of haematology"},{"issue":"45","key":"ref14","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1038\/onc.2013.524","article-title":"Protein kinase C and cancer: what we know and what we do not","volume":"33","author":"R Garg","year":"2014","journal-title":"Oncogene"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nri3487","article-title":"New insights into pre-BCR and BCR signalling with relevance to B cell malignancies","volume":"13","author":"RC Rickert","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"ref16","first-page":"3394","article-title":"NF-kappa B activation induced by T cell receptor\/CD28 costimulation is mediated by protein kinase C-theta","volume":"97","author":"N Coudronniere","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cbi.2015.10.004","article-title":"Inhibition of crosstalk between Bcr-Abl and PKC signaling by PEITC, augments imatinib sensitivity in chronic myelogenous leukemia cells","volume":"242","author":"M Roy","year":"2015","journal-title":"Chem Biol Interact"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/jcb.23090","article-title":"Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells","volume":"112","author":"PP Ruvolo","year":"2011","journal-title":"J Cell Biochem"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.leu.2403275","article-title":"PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation","volume":"18","author":"T Jiffar","year":"2004","journal-title":"Leukemia"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1773-2247(09)50004-4","article-title":"Phospholipid\/deoxycytidine analogue prodrugs for the treatment of cancer","volume":"19","author":"KA Pickin","year":"2009","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrc2110","article-title":"Protein kinase C and other diacylglycerol effectors in cancer","volume":"7","author":"EM Griner","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"ref22","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1182\/blood-2010-08-301267","article-title":"Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"117","author":"N Boulos","year":"2011","journal-title":"Blood"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V99.3.863","article-title":"Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study","volume":"99","author":"L Annino","year":"2002","journal-title":"Blood"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2002.07.116","article-title":"Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia","volume":"20","author":"C Linker","year":"2002","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1182\/blood-2015-03-636548","article-title":"Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia","volume":"126","author":"DY Kim","year":"2015","journal-title":"Blood"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/leu.2012.324","article-title":"Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome\u2014positive acute lymphoblastic leukemia","volume":"27","author":"OG Ottmann","year":"2013","journal-title":"Leukemia"},{"issue":"22","key":"ref27","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1056\/NEJMoa1205127","article-title":"Ponatinib in refractory Philadelphia chromosome-positive leukemias","volume":"367","author":"JE Cortes","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3109\/10428194.2016.1144882","article-title":"Sustaining integrating imatinib and interferon-\u03b1 into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation","volume":"57","author":"P Kuang","year":"2016","journal-title":"Leukemia & Lymphoma"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/onc.2009.374","article-title":"Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR\/p70S6-kinase pathway","volume":"29","author":"B Markova","year":"2010","journal-title":"Oncogene"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.1771409","article-title":"Mouse models of human AML accurately predict chemotherapy response","volume":"23","author":"J Zuber","year":"2009","journal-title":"Genes & development"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood-2008-02-140665","article-title":"Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia","volume":"112","author":"K Porkka","year":"2008","journal-title":"Blood"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"AK Fielding","year":"2007","journal-title":"Blood"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.3078","article-title":"Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL","volume":"19","author":"G Tzoneva","year":"2013","journal-title":"Nat Med"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nm.3840","article-title":"Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL","volume":"21","author":"B Li","year":"2015","journal-title":"Nat Med"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.leukres.2005.01.013","article-title":"Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells","volume":"29","author":"RP Goncalves","year":"2005","journal-title":"Leukemia research"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00043426-200405000-00006","article-title":"Serum lipid alterations in acute lymphoblastic leukemia of childhood","volume":"26","author":"M Moschovi","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/1061186X.2010.513712","article-title":"Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain","volume":"18","author":"A Zensi","year":"2010","journal-title":"J Drug Target"},{"issue":"31","key":"ref38","doi-asserted-by":"crossref","first-page":"10441","DOI":"10.1523\/JNEUROSCI.5943-09.2010","article-title":"Lipoprotein particles cross the blood-brain barrier in Drosophila","volume":"30","author":"M Brankatschk","year":"2010","journal-title":"J Neurosci"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/jpet.103.050336","article-title":"Protein kinase C mediates repair of mitochondrial and transport functions after toxicant-induced injury in renal cells","volume":"306","author":"G Nowak","year":"2003","journal-title":"J Pharmacol Exp Ther"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0179798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T23:25:40Z","timestamp":1719271540000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0179798"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,23]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0179798","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,23]]}}}